COVID-19 Update – Nurse Practitioner

  Price  $6.95

  Credits  1.5


In December 2019, a novel coronavirus was linked to a deadly outbreak of pneumonia in Wuhan, China. This virus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), quickly spread around the globe. The disease it causes, COVID-19, is a spectrum of acute and long-term syndromes ranging from asymptomatic infection to acute respiratory distress syndrome (ARDS). A variety of coagulopathic, neurologic, and psychiatric complications may also occur. The mortality rate has been staggering, with over 1.6 million deaths worldwide and over 302,000 deaths in the US as of December 15th, 2020. The US leads the world in the number of cases and deaths. Economic changes caused by COVID-19 are many and the impact is just beginning to be understood. Over the short term, COVID-19 has resulted in an increased unemployment rate, decreased hours of work / labor force participation, and in some cases, a significant loss of wages. Lost productivity resulting from illness must be accounted for, as well as the changes in how people can or cannot safely work, given the risks of transmission. Social distancing, quarantines, and travel restrictions have reduced the work force across all economic sectors. Those whose work requires proximity to others are generally more affected, while individuals who can work remotely are less so.


Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Nurse Practitioner

Christina G. Rivera
PharmD, BCPS
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  • Identify risk factors for severe COVID-19 and recognize key differences between influenza and COVID-19 symptoms. Compare and contrast the tests used to detect COVID-19 infection.
  • Discuss the primary therapeutic agents for COVID-19; include effectiveness, side effects, and dosing. 
  • Counsel patients on the use of supplements, prevention, and supportive care for mild cases of COVID-19.

Course Accreditation

  • Activity Type:
  • CE Broker
  • Universal Activity Number:
    Nurse Practitioner : 0798-0000-21-188-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.